Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae
暂无分享,去创建一个
A. Blom | B. Dahlbäck | S. Ram | M. Cullinane | S. Gulati | D. McQuillen | B. Monks | C. O'Connell | R. Boden | C. Elkins | M. Pangburn | P. Rice | Brian G. Monks | M. K. Pangburn
[1] M. Ward,et al. Gonococci in Urethral Exudates possess a Virulence Factor lost on Subculture , 1970, Nature.
[2] L. Lee,et al. Secretory IgA antibody responses to Neisseria gonorrhoeae in the genital secretions of infected females. , 1976, The Journal of infectious diseases.
[3] V. Nussenzweig,et al. Human C4-binding protein. I. Isolation and characterization , 1978, The Journal of experimental medicine.
[4] V. Nussenzweig,et al. Human C4-binding protein. II. Role in proteolysis of C4b by C3b- inactivator , 1978, The Journal of experimental medicine.
[5] G. Brooks,et al. Serum bactericidal action and activation of the classic and alternate complement pathways by Neisseria gonorrhoeae. , 1978, The Journal of laboratory and clinical medicine.
[6] V. Nussenzweig,et al. Presence of a C4-Binding Protein (C4-bp) in Human Serum , 1978 .
[7] G. Mcneillage,et al. Secretory antibody response of the cervix to infection with Neisseria gonorrhoeae. , 1979, The British journal of venereal diseases.
[8] C. Penn,et al. Phenotypically determined resistance of Neisseria gonorrhoeae to normal human serum: environmental factors in subcutaneous chambers in guinea pigs. , 1979, Journal of general microbiology.
[9] B. Boettcher,et al. The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies. , 1979, Fertility and sterility.
[10] V. Nussenzweig,et al. The role of C4-binding protein and {beta }1H in proteolysis of C4b and C3b , 1979, The Journal of experimental medicine.
[11] V. Nussenzweig,et al. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Kasper,et al. Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease. , 1980, Journal of immunology.
[13] H. Smith,et al. Induction of phenotypically determined resistance of Neisseria gonorrhoeae to human serum by factors in human serum. , 1981, Journal of general microbiology.
[14] H. Nikaido,et al. Protein I of Neisseria gonorrhoeae outer membrane is a porin , 1981 .
[15] C. Penn,et al. Factors affecting the induction of phenotypically determined serum resistance of Neisseria gonorrhoeae grown in media containing serum or its diffusible components. , 1981, Journal of general microbiology.
[16] T. Meyer,et al. Pilus expression in neisseria gonorrhoeae involves chromosomal rearrangement , 1982, Cell.
[17] G. Pier,et al. Immunological basis of serum resistance of Neisseria gonorrhoeae. , 1982, Journal of general microbiology.
[18] J. Cannon,et al. Confirmation of association of protein I serotype of Neisseria gonorrhoeae with ability to cause disseminated infection , 1983, Infection and immunity.
[19] P. Rice,et al. Disseminated Gonococcal Infection: A Prospective Analysis of 49 Patients and a Review of Pathophysiology and Immune Mechanisms , 1983, Medicine.
[20] T. Koide,et al. Human C4b‐binding protein, C4bp , 1983, FEBS letters.
[21] B. Dahlbäck. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. , 1983, The Biochemical journal.
[22] C. Smith,et al. Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Holmes,et al. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. , 1984, The Journal of infectious diseases.
[24] B. Dahlbäck,et al. Ultrastructure of C4b-binding protein fragments formed by limited proteolysis using chymotrypsin. , 1984, The Journal of biological chemistry.
[25] G. Schoolnik,et al. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. , 1985, Journal of Infectious Diseases.
[26] F. Plummer,et al. Correlation of auxotype and protein I type with expression of disease due to Neisseria gonorrhoeae. , 1985, The Journal of infectious diseases.
[27] J. Griffiss,et al. Elaboration of a 3.6-kilodalton lipooligosaccharide, antibody against which is absent from human sera, is associated with serum resistance of Neisseria gonorrhoeae , 1985, Infection and immunity.
[28] P. Rice,et al. Bactericidal antibody response of normal human serum to the lipooligosaccharide of Neisseria gonorrhoeae. , 1986, The Journal of infectious diseases.
[29] K. Holmes,et al. Epidemiological analysis of Neisseria gonorrhoeae in the Federal Republic of Germany by auxotyping and serological classification using monoclonal antibodies. , 1986, Genitourinary medicine.
[30] P. Densen,et al. Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. Role of antibodies directed against lipooligosaccharides. , 1987, The Journal of clinical investigation.
[31] M. Inouye. Bacterial outer membranes as model systems , 1987 .
[32] E. Gotschlich,et al. Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I- adjuvant preparations , 1988, The Journal of experimental medicine.
[33] J. Poolman. Gonococci and Meningococci , 1988, Springer Netherlands.
[34] G. Nemerow,et al. Epstein-Barr virus regulates activation and processing of the third component of complement , 1988, The Journal of experimental medicine.
[35] M. Apicella,et al. Selection and immunochemical analysis of lipooligosaccharide mutants of Neisseria gonorrhoeae , 1988, Infection and immunity.
[36] N. Carbonetti,et al. Genetics of protein I of Neisseria gonorrhoeae: construction of hybrid porins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[37] B. Dahlbäck,et al. Novel subunit in C4b-binding protein required for protein S binding. , 1988, The Journal of biological chemistry.
[38] G. Schumacher. Immunology of spermatozoa and cervical mucus. , 1988, Human reproduction.
[39] J. Cole,et al. Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. , 1988, Microbial pathogenesis.
[40] J. Cole,et al. Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum. , 1988, Journal of general microbiology.
[41] L Slaney,et al. Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. , 1989, The Journal of clinical investigation.
[42] E. Gotschlich,et al. The construction and characterization of Neisseria gonorrhoeae lacking protein III in its outer membrane , 1989, Journal of Experimental Medicine.
[43] S. Ho,et al. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.
[44] T. Aso,et al. Molecular cloning of the cDNA coding for proline-rich protein (PRP): identity of PRP as C4b-binding protein. , 1989, Biochemical and biophysical research communications.
[45] S. E. West,et al. Genetic loci and linkage associations in Neisseria gonorrhoeae and Neisseria meningitidis , 1989, Clinical Microbiology Reviews.
[46] T. Hackeng,et al. Identification of Different Forms of Human C4b-Binding Protein Lacking β-Chain and Protein S Binding Ability , 1990, Thrombosis and Haemostasis.
[47] M. Dominguez-Bello,et al. Degradation of mimosine, 2,3-dihydroxy pyridine and 3-hydroxy-4(1H)-pyridine by bacteria from the rumen of sheep in Venezuela , 1990 .
[48] C. Elkins,et al. Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibiotics , 1990, Molecular microbiology.
[49] M. Wilson,et al. Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. , 1990, The Journal of infectious diseases.
[50] E. Giovanetti,et al. Antibiotic resistance in foodborne listeria , 1991, The Lancet.
[51] J. Sarwar,et al. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae , 1991, Infection and immunity.
[52] A. Kéchrid. [Sensitivity of Neisseria gonorrhoeae to antibiotics]. , 1991, Archives de l'Institut Pasteur de Tunis.
[53] P. Lambden,et al. Sequence analysis and relationships between meningococcal class 3 serotype proteins and other porins from pathogenic and non-pathogenic Neisseria species. , 1992, FEMS microbiology letters.
[54] H. Young,et al. A serovar analysis of heterosexual gonorrhoea in Edinburgh 1986-90. , 1992, Genitourinary medicine.
[55] D. Stirewalt,et al. Antibodies to N‐terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated , 1992, Molecular microbiology.
[56] F. Plummer,et al. Bacterial antigenic variation, host immune response, and pathogen-host coevolution , 1993, Infection and immunity.
[57] J. Griffiss,et al. The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection. Evidence for a new glycosylation pathway of the gonococcal lipooligosaccharide. , 1994, The Journal of biological chemistry.
[58] C. Elkins,et al. Cloning and constitutive expression of structural genes encoding gonococcal porin protein in Escherichia coli and attenuated Salmonella typhimurium vaccine strains. , 1994, Gene.
[59] A. Campana,et al. Investigations on the cell type responsible for the endometrial secretion of complement component 3 (C3). , 1994, Human reproduction.
[60] P. Zipfel,et al. Complement factor H and related proteins: an expanding family of complement-regulatory proteins? , 1994, Immunology today.
[61] S. Gulati,et al. Complement-mediated bacterial killing assays. , 1994, Methods in enzymology.
[62] B. Spratt,et al. Sequence evolution of the porB gene of Neisseria gonorrhoeae and Neisseria meningitidis: evidence of positive Darwinian selection. , 1995, Molecular biology and evolution.
[63] M. Weir,et al. Gonococcal serovar patterns in Glasgow: 1990-1992. , 1995, British journal of biomedical science.
[64] G. Lindahl,et al. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. , 1995, Journal of immunology.
[65] E. Johnsson,et al. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. , 1996, Journal of immunology.
[66] K. Isaacson,et al. Localization of the expression of complement component 3 in the human endometrium by in situ hybridization. , 1996, The Journal of clinical endocrinology and metabolism.
[67] J. Lupski,et al. Rapid determination of outbreak-related strains of Neisseria meningitidis by repetitive element-based polymerase chain reaction genotyping. , 1996, The Journal of infectious diseases.
[68] T. Murphy,et al. Mechanisms of Recurrent Otitis Media: Importance of the Immune Response to Bacterial Surface Antigens a , 1997, Annals of the New York Academy of Sciences.
[69] F. Mooi,et al. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin , 1997, Infection and immunity.
[70] B. Dahlbäck,et al. The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function. , 1997, The Biochemical journal.
[71] D. Dorward,et al. Porin polypeptide contributes to surface charge of gonococci , 1997, Journal of bacteriology.
[72] J. Atkinson,et al. Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function. , 1998, Journal of immunology.
[73] S. Ram,et al. A Novel Sialic Acid Binding Site on Factor H Mediates Serum Resistance of Sialylated Neisseria gonorrhoeae , 1998, The Journal of experimental medicine.
[75] K. Berggård,et al. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. , 1998, Journal of immunology.
[76] D. Covell,et al. Structural investigation of C4b‐binding protein by molecular modeling: Localization of putative binding sites , 1998, Proteins.
[77] P. Rice,et al. Human immune response to monoclonal antibody — defined epitopes of Neisseria gonorrhoeae lipooligosaccharides , 1998 .
[78] A. Blom,et al. A Cluster of Positively Charged Amino Acids in the C4BP α-Chain Is Crucial for C4b Binding and Factor I Cofactor Function* , 1999, The Journal of Biological Chemistry.
[79] R. Brunham,et al. Genetic Diversity and Mosaicism at the por Locus ofNeisseria gonorrhoeae , 1999, Journal of bacteriology.
[80] T. Heeren,et al. Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. , 1999, The Journal of infectious diseases.
[81] M. Hobbs,et al. Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. , 1999, The Journal of infectious diseases.
[82] S. Meri,et al. The factor H protein family. , 1999, Immunopharmacology.
[83] D. Weiner,et al. Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae. , 1999, American journal of epidemiology.
[84] A. Blom,et al. Human C4b-Binding Protein Has Overlapping, But Not Identical, Binding Sites for C4b and Streptococcal M Proteins1 , 2000, The Journal of Immunology.
[85] F. Babl,et al. Neonatal gonococcal arthritis after negative prenatal screening and despite conjunctival prophylaxis. , 2000, The Pediatric infectious disease journal.
[86] D. Pérez-Caballero,et al. Assessment of the interaction of human complement regulatory proteins with group A Streptococcus. Identification of a high‐affinity group A Streptococcus binding site in FHL‐1 , 2000, European journal of immunology.